Keyword: multiple myeloma

News

FDA Stops US Merck Keytruda Trials

12.07.2017 - The US Food and Drug Administration (FDA) has placed a clinical hold on three phase 3 multiple myeloma studies testing US drugmaker Merck’s Keytruda (pembrolizumab) in combination...

News

US Merck Halts Trial Enrollment After Deaths

14.06.2017 - US pharmaceutical giant Merck has announced it is suspending new enrollments in two phase 3 multiple myeloma studies with its blockbuster immunotherapy drug Keytruda (pembrolizumab...

News

J&J Drugs Arm Announces 10 Blockbuster Filings by 2019

21.05.2015 - Johnson & Johnson's Janssen Pharmaceuticals offshoot has told analysts it plans to seek regulatory approval for more than 10 new drugs up to 2019, each with the potential to...